Bronchiectasis Etiologies: From Idiopathic to Immune Deficiency

In "Bronchiectasis Etiologies: From Idiopathic to Immune Deficiency," the panel explores the conditions most often responsible for bronchiectasis and the psychological toll the disease can carry.

Dr. Khabbaza walks through the etiologies he encounters most often in his bronchiectasis practice. Idiopathic disease remains the single most frequent category, he explains, meaning no clear cause has yet been identified. Among the identifiable causes, post-infectious bronchiectasis is the most common, often traced back to childhood respiratory illnesses such as pertussis or measles. He suggests that patients with an underlying genetic susceptibility may experience a post-infectious hit on top of that predisposition, compounding lung damage over time.

Reduced immunoglobulin levels are another etiology Dr. Khabbaza sees regularly, occurring both in patients on immunosuppressive medications and in those with no clear trigger. He finds these cases particularly rewarding to identify because patients often respond well to immunoglobulin replacement therapy. He argues that pursuing an initial workup for treatable causes is worthwhile, even though airway clearance, antibiotics, and anti-inflammatory therapy remain the mainstay treatments regardless of etiology, because identifying a specific cause early can slow the underlying inflammatory process.

Dr. Basavaraj highlights anxiety and depression as an important comorbidity, noting that the daily burden of treatments, frequent outpatient visits, and uncertainty about disease course all contribute to psychological distress.

Dr. Khabbaza agrees, adding that patients who do not understand their disease often fare worse psychologically, particularly if they turn to unreliable information online. He finds that educated, informed patients and families cope significantly better once they understand that disease severity varies widely and that multiple treatment approaches exist.

Dr. Metersky notes that many patients privately fear dying from bronchiectasis, even when they do not raise the concern directly. He makes a point of reassuring every new patient that the vast majority of people with bronchiectasis will not die from it. Dr. Basavaraj adds that reviewing CT scans directly with patients helps them understand their lungs and reduces anxiety about the unknown.

In "The Vicious Vortex: Inflammation's Role in Bronchiectasis," the panel will unpack the vicious vortex of inflammation that drives bronchiectasis from mild to severe disease.